IRIS Accounts Production v25.1.0.734 09785835 Board of Directors 1.10.23 30.9.24 30.9.24 false true false false false 6953 22323 16481 6953 6953 22323 16481 6953 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh097858352023-09-30097858352024-09-30097858352023-10-012024-09-30097858352022-09-30097858352022-10-012023-09-30097858352023-09-3009785835ns15:EnglandWales2023-10-012024-09-3009785835ns14:PoundSterling2023-10-012024-09-3009785835ns10:Director12023-10-012024-09-3009785835ns10:PrivateLimitedCompanyLtd2023-10-012024-09-3009785835ns10:Micro-entities2023-10-012024-09-3009785835ns10:AuditExempt-NoAccountantsReport2023-10-012024-09-3009785835ns10:FullAccounts2023-10-012024-09-3009785835ns10:Director2422023-09-3009785835ns10:Director2422022-09-3009785835ns10:Director2422023-10-012024-09-3009785835ns10:Director2422022-10-012023-09-3009785835ns10:Director2422024-09-3009785835ns10:Director2422023-09-3009785835ns5:CurrentFinancialInstruments2024-09-3009785835ns5:CurrentFinancialInstruments2023-09-3009785835ns10:RegisteredOffice2023-10-012024-09-3009785835ns10:Director22023-10-012024-09-30097858351ns10:Director12023-09-30097858351ns10:Director12022-09-30097858351ns10:Director12023-10-012024-09-30097858351ns10:Director12022-10-012023-09-30097858351ns10:Director12024-09-30097858351ns10:Director12023-09-30
REGISTERED NUMBER: 09785835 (England and Wales)















UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 30 SEPTEMBER 2024

FOR

PRIME ANAESTHETICS LTD

PRIME ANAESTHETICS LTD (REGISTERED NUMBER: 09785835)

CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2024










Page

Balance Sheet 1


PRIME ANAESTHETICS LTD (REGISTERED NUMBER: 09785835)

BALANCE SHEET
30 SEPTEMBER 2024

2024 2023
£    £    £    £   
FIXED ASSETS 2,567 3,458

CURRENT ASSETS 283,298 240,568

CREDITORS
Amounts falling due within one year (49,723 ) (53,062 )
NET CURRENT ASSETS 233,575 187,506
TOTAL ASSETS LESS CURRENT
LIABILITIES

236,142

190,964

CAPITAL AND RESERVES 236,142 190,964

NOTES TO THE FINANCIAL STATEMENTS

1. STATUTORY INFORMATION

Prime Anaesthetics Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address are as below:

Registered number: 09785835

Registered office: Court House
Court Road
Bridgend
CF31 1BE

The presentation currency of the financial statements is the Pound Sterling (£).


2. AVERAGE NUMBER OF EMPLOYEES

The average number of employees during the year was 2 (2023 - 2 ) .

PRIME ANAESTHETICS LTD (REGISTERED NUMBER: 09785835)

BALANCE SHEET - continued
30 SEPTEMBER 2024

NOTES TO THE FINANCIAL STATEMENTS

3. DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to directors subsisted during the years ended 30 September 2024 and 30 September 2023:

2024 2023
£    £   
Dr J Leary and Mrs C Leary
Balance outstanding at start of year 6,953 22,323
Amounts advanced 16,481 6,953
Amounts repaid (6,953 ) (22,323 )
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year 16,481 6,953



The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 September 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 September 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the Board of Directors and authorised for issue on 3 May 2025 and were signed on its behalf by:





Dr J Leary - Director